TearClear

Boston, United States

TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.

$11.8M raised

Jul 2023

Venture - Series Unknown

Top Investors

Visionary Venture FundBluestem CapitalFlying L Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TearClear raised?

TearClear has raised $11.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.

Who are TearClear's investors?

TearClear's investors include Visionary Venture Fund, Bluestem Capital, Flying L Partners.

Where is TearClear headquartered?

TearClear is headquartered in Boston, United States.

What does TearClear do?

TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.

What stage is TearClear at?

TearClear is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 11, 2023.

MLA

"TearClear — Funding & Investors." VCBacked, July 11, 2023, https://www.vcbacked.co/company/tearclear. Accessed June 13, 2026.

APA

VCBacked. (2023). TearClear — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/tearclear

Wikipedia (cite web)

{{cite web |title=TearClear — Funding & Investors |url=https://www.vcbacked.co/company/tearclear |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 11, 2023.